Key facts
- Notable investors include Gaingels, Arben Ventures, The Pitch Fund & Syndicate.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Above Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Above Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Above Health
Developer of a healthcare technology platform designed for allergy and asthma management. The company's platform integrates AI-powered diagnostics, smart medical devices such as inhalers and wearables, and personalized treatment plans delivered via telehealth and in-person consultations, enabling families and individuals affected by allergic conditions to monitor symptoms in time, identify triggers, reduce emergency visits, and receive continuous care from board-certified specialists.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2024
- Employees
- 2
- Website
- above.health/
- Ownership
- Privately Held (backing)
Above Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Above Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Above Health in its N-PORT filings yet. We sweep new filings monthly.